TickerFacts.

Scynexis Inc (SCYX): Net Income

Annual figures by period end, from SEC filings.

-$8.61M
Year ended 2025-12-31
-$10.23M
Trailing 12 months to 2026-06-30
$67.04M2013-12-31: -$30.46M2014-12-31: -$4.23M2015-12-31: -$32.62M2016-12-31: -$29.99M2017-12-31: -$25.06M2018-12-31: -$12.47M2019-12-31: -$53.71M2020-12-31: -$55.19M2021-12-31: -$32.87M2022-12-31: -$62.81M2023-12-31: $67.04M2024-12-31: -$21.29M2025-12-31: -$8.61M-$8.61M
2013-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$8.61Mn/m2026-03-04, From 2025-01-01
2024-12-31-$21.29Mn/m2026-03-04, From 2024-01-01
2023-12-31$67.04Mn/m2025-03-12, From 2023-01-01
2022-12-31-$62.81Mn/m2024-03-28, From 2022-01-01
2021-12-31-$32.87Mn/m2023-03-31, From 2021-01-01
2020-12-31-$55.19Mn/m2022-03-29, From 2020-01-01
2019-12-31-$53.71Mn/m2021-03-29, From 2019-01-01
2018-12-31-$12.47Mn/m2020-03-11, From 2018-01-01
2017-12-31-$25.06Mn/m2019-03-14, From 2017-01-01
2016-12-31-$29.99Mn/m2017-03-13, From 2016-01-01
2015-12-31-$32.62Mn/m2017-03-13, From 2015-01-01
2014-12-31-$4.23Mn/m2017-03-13, From 2014-01-01
2013-12-31-$30.46Mn/a2015-03-30, From 2013-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Scynexis Inc (SCYX)2025-12-31-$8.61Mn/m
CASI Pharmaceuticals, Inc. (CASIF)2025-12-31-$48.06Mn/m
Evofem Biosciences, Inc. (EVFM)2025-12-31$391.0Kn/m
Sol-Gel Technologies Ltd. (SLGL)2025-12-31-$6.13Mn/m
NewAmsterdam Pharma Co N.V. (NAMS)2025-12-31-$203.82Mn/m
Alumis Inc. (ALMS)2025-12-31-$243.32Mn/m
Entrada Therapeutics, Inc. (TRDA)2025-12-31-$143.75Mn/m
uniQure N.V. (QURE)2025-12-31-$198.97Mn/m
Celularity Inc (CELU)2025-12-31-$91.72Mn/m

Compare SCYX, CASIF, EVFM, SLGL side by side · Screen every company in Pharmaceutical Preparations ↗